BioCentury
ARTICLE | Company News

Invitae sales and marketing update

September 1, 2014 7:00 AM UTC

Invitae launched PALB2 testing worldwide to diagnose cancer. The test includes full sequencing and deletion/duplication analysis of the partner and localizer of BRCA2 (PALB2) gene for $1,500 in the ...